For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200214:nRSN0317Da
RNS Number : 0317D Ergomed plc 14 February 2020
PRESS RELEASE
Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealings
Guildford, UK - 14 February 2020 - Ergomed plc (LSE: ERGO) ("Ergomed" or the
"Company"), a company focused on providing specialised services to the
pharmaceutical industry, announces the purchase of ordinary shares of 1
pence each ("Shares") by four Directors of the Company.
PDMR Position Shares acquired Purchase price (£) Date of purchase Resultant shareholding in the Company (Shares)
Rolf Soderstrom((1)) Non-Executive Director 10,000 4.56 11 February 2020 10,000
Dr Jim Esinhart Non-Executive Director 10,000 4.56 11 February 2020 10,000
Ian Johnson Non-Executive Director 10,000 4.56 11 February 2020 10,000
Lewis Cameron Chief Operating Officer 10,910 4.56 12 February 2020 10,910
(1) Note: includes Shares acquired by Linda Davey, being a person closely
associated with Rolf Soderstrom.
The notification below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated ("PCA") with them.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Rolf Soderstrom
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ergomed Plc
b) Legal Entity Identifier 213800BVS8I9VMC1AP84
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BN7ZCY67
b) Nature of the transaction Purchase of Shares
c) Currency GBP
d) Price(s) and volume(s) Price(s) Volume(s)
£4.56 5,000
e) Aggregated information Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per
share
- Aggregated volume
Aggregated: £22,800.00
- Price
- Aggregated total
f) Date of the transaction 11 February 2020
g) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Linda Davey
2 Reason for the notification
a) Position/status PCA with Rolf Soderstrom, Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ergomed Plc
b) Legal Entity Identifier 213800BVS8I9VMC1AP84
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BN7ZCY67
b) Nature of the transaction Purchase of Shares
c) Currency GBP
d) Price(s) and volume(s) Price(s) Volume(s)
£4.56 5,000
e) Aggregated information Volume: 5,000 ordinary shares of 1 pence each, purchase price of 456 pence per
share
- Aggregated volume
Aggregated: £22,800.00
- Price
- Aggregated total
f) Date of the transaction 11 February 2020
g) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jim Esinhart, PhD
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ergomed Plc
b) Legal Entity Identifier 213800BVS8I9VMC1AP84
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BN7ZCY67
b) Nature of the transaction Purchase of Shares
c) Currency GBP
d) Price(s) and volume(s) Price(s) Volume(s)
£4.56 10,000
e) Aggregated information Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence
per share
- Aggregated volume
Aggregated: £45,600.00
- Price
- Aggregated total
f) Date of the transaction 11 February 2020
g) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Ian Johnson
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ergomed Plc
b) Legal Entity Identifier 213800BVS8I9VMC1AP84
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BN7ZCY67
b) Nature of the transaction Purchase of Shares
c) Currency GBP
d) Price(s) and volume(s) Price(s) Volume(s)
£4.56 10,000
e) Aggregated information Volume: 10,000 ordinary shares of 1 pence each, purchase price of 456 pence
per share
- Aggregated volume
Aggregated: £45,600.00
- Price
- Aggregated total
f) Date of the transaction 11 February 2020
g) Place of the transaction London Stock Exchange, AIM
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Lewis Cameron
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Ergomed Plc
b) Legal Entity Identifier 213800BVS8I9VMC1AP84
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BN7ZCY67
b) Nature of the transaction Purchase of Shares
c) Currency GBP
d) Price(s) and volume(s) Price(s) Volume(s)
£4.56 10,910
e) Aggregated information Volume: 10,910 ordinary shares of 1 pence each, purchase price of 456 pence
per share
- Aggregated volume
Aggregated: £49,749.60
- Price
- Aggregated total
f) Date of the transaction 12 February 2020
g) Place of the transaction London Stock Exchange, AIM
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402 975
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Huw Jeremy (Nominated Adviser)
James Black (Broker)
Consilium Strategic Communications - for UK enquiries Tel: +44 (0) 20 3709 5700
Chris Gardner / Sue Stuart ergomed@consilium-comms.com
Matthew Neal / Olivia Manser
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning
all phases of clinical trials, post-approval pharmacovigilance and medical
information. Ergomed's fast-growing, profitable services business includes a
full range of high-quality contract research and clinical trial management
(CRO) services under the Ergomed brand together with an industry-leading suite
of specialist pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand, and an internationally recognized specialist expertise
in orphan drug development, under the PSR brand. For further information,
visit: http://ergomedplc.com (http://ergomedplc.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
. END DSHKZGMZVDZGGZG